'Cocktail' of compounds improves brain function in rodents

MIT researchers have shown that a cocktail containing three compounds normally in the blood stream promotes growth of new brain connections and improves cognitive function in rodents. The treatment is now being tested in Alzheimer's patients and could hold promise for other brain diseases and injuries.

The mixture, which includes a type of omega-3 fatty acid, is part of a new approach to attacking Alzheimer's. That approach focuses on correcting the loss of synapses, or connections between neurons, which characterizes the disease.

For the past 30 years, researchers have tried targeting the clumps of misfolded proteins, known as amyloid beta plaques, found in the brains of Alzheimer's patients. However, that approach has not yielded any effective treatments for the disease, which affects an estimated four million to five million Americans.

“It's been very frustrating,” said Richard Wurtman, the Cecil H. Green Distinguished Professor of Neuropharmacology and senior author of a paper on the new work published in the November issue of Brain Research. “Nobody has demonstrated that if you prevent formation of the amyloid, people get better.”

In December, a group of Alzheimer's researchers, including Wurtman, will participate in a symposium with the goal of developing a public policy to promote new approaches to Alzheimer's research. Organizers of the symposium believe that the current system of dementia research is “broken” and needs to be fixed.

Alzheimer's researchers agree that the cognitive decline seen in Alzheimer's patients is caused by loss of brain synapses. Wurtman and others theorize that restoring some of those synapses could provide an effective treatment, analogous to giving L-dopa to Parkinson's patients. Such treatments don't cure the disease but can restore significant brain function, said Wurtman.

Synapses, where information is passed between neurons, play a critical role in learning and memory. Messages travel from a presynaptic neuron to a postsynaptic cell.

In the Brain Research paper, the MIT team reported that rodents given a cocktail of DHA (a type of omega-3 fatty acid), uridine and choline showed a greatly increased concentration of dendritic spines, which receive messages in the postsynaptic neuron. That indicates that synapse regeneration has occurred, which is unusual, Wurtman said.

Synapse regrowth could also prove an effective treatment for other brain diseases, such as Parkinson's, or for brain injuries, he said.

The researchers found that rodents who received the treatment performed much better on tests of cognitive ability (specifically, navigating a water maze). Sarah Holguin, an MIT graduate student in brain and cognitive sciences, presented those results at the Society for Neuroscience annual meeting earlier this month.

Some of the rats in the studies received all three compounds and some received only one. The improvements in synapse growth and cognitive ability were greatest in the rats given all three.

Omega-3 fatty acids are not produced in the body but are found in a variety of sources, including fish, eggs, flaxseed and meat from grass-fed animals. Choline can be synthesized in the body and obtained through the diet; it is found in meats, nuts and eggs. Uridine cannot be obtained from food sources, but is a component of human breast milk and can be produced in the body.

The cocktail of compounds is now in clinical studies in Europe.

Other authors of the Brain Research paper were Toshimasa Sakamoto, the first author and a research affiliate in the Department of Brain and Cognitive Sciences (BCS), and Mehmet Cansev, a BCS postdoctoral associate.

Source: MIT, by Anne Trafton

Related stories:

Study confirms benefit of combination therapy for Alzheimer's disease
Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities. Results from the first long-term study of the real-world use of Alzheimer's drugs, published by researchers from Massachusetts General Hospital in the July/September issue of Alzheimer Disease and Associated Disorders, support a level of effectiveness that may not be immediately apparent to patients or their family members.
A blood marker may indicate Alzheimer’s risk
A simple blood test capable of predicting if a person might develop Alzheimer’s disease is within sight, and could eventually be used to help scientists reverse onset of the disease in those most at risk.
Do mammals think in 3-D?
A team of neuroscientists at University College London (UCL) has begun to discover how the brain maps three-dimensional space. The work could one day aid in the understanding and treatment of Alzheimer’s disease, which involves the same area of the brain as encodes space.
Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal
Adults with type 2 diabetes who eat unhealthy, high-fat meals may experience memory declines immediately afterward, but this can be offset by taking antioxidant vitamins with the meal, according to new research from Baycrest.
Known Genetic Risk Alzheimer's In Whites Also Places Blacks At Risk
A commonly recognized gene that places one at risk for Alzheimer’s disease does not discriminate between blacks and whites, according to new research led by Florida State University.

Gene variation linked to earlier onset of Alzheimer's symptoms
Investigators at Washington University School of Medicine in St. Louis have identified a genetic variation associated with an earlier age of onset in Alzheimer's disease.
Plant flavonoid found to reduce inflammatory response in the brain
Researchers at the University of Illinois report this week that a plant compound found in abundance in celery and green peppers can disrupt a key component of the inflammatory response in the brain. The findings have implications for research on aging and diseases such as Alzheimer’s and multiple sclerosis.
Green tea compounds beat OSA-related brain deficits
Chemicals found in green tea may be able to stave off the cognitive deficits that occur with obstructive sleep apnea (OSA), according to a new study published in the second issue for May of the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

News discussion:

Medicine & Health news